Hormonal Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
Conditions:   Castration Resistant Prostate Cancer;   Castration Sensitive Prostate Cancer Interventions:   Drug: Piflufolastat;   Procedure: Positron Emission Tomography/Computed Tomography;   Procedure: Positron Emission Tomography/Magnetic Resonance Imaging;   Procedure: Biospecimen Collection;   Other: Electronic Health Record Review Sponsors:   OHSU Knight Cancer Institute;   Oregon Health and Science University;   Progenics Pharmaceuticals, Inc., a Lantheus company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials